Physician profile
Cindy G Besson
NPI 1265426019
$2,187.82
in general payments reported to CMS, 2019-2025
25 companies · $24.52 in 2025
The $24.52 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $627 · 2021: $751 · 2022: $249 · 2023: $188 · 2024: $119 · 2025: $24.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $512.76 | 2019-2024 | Ubrelvy, Qulipta, Lo Loestrin Fe |
| Amgen INC. | $325.07 | 2019-2023 | Evenity, Prolia |
| Daiichi Sankyo INC. | $235.22 | 2021-2022 | |
| Therapeuticsmd, INC. | $177.32 | 2019-2022 | |
| Pfizer INC. | $169.90 | 2019-2024 | |
| Astellas Pharma US INC | $155.36 | 2020-2024 | Veozah, Myrbetriq |
| Upsher-Smith Laboratories LLC | $71.86 | 2020 | |
| Hologic Sales and Service, LLC | $63.68 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $59.42 | 2019-2020 | |
| Vivus LLC | $53.88 | 2020 | |
| Aspira Women'S Health INC | $40.29 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $39.29 | 2021-2023 | |
| Evofem Biosciences, INC. | $35.68 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.73 | 2019-2020 | |
| Agile Therapeutics, INC. | $26.24 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $24.52 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Vertical Pharmaceuticals, LLC | $24.51 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $23.10 | 2023 | Vivjoa |
| Ethicon US, LLC | $21.91 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $19.89 | 2021 | |
| Myovant Sciences INC. | $18.73 | 2021 | |
| Exeltis, USA INC. | $17.00 | 2020 | |
| Coopersurgical, INC. | $15.79 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.38 | 2022 | |
| Avion Pharmaceuticals | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Besson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.